Intravenous immunoglobulin preparation attenuates LPS-induced production of pro-inflammatory cytokines in human monocytic cells by modulating TLR4-mediated signaling pathways

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 9, 2012, Pages 891-898

  Murakami, Kazuki ^a   Suzuki, Chiaki ^a   Kobayashi, Fujio ^a   Nakano, Atsushi ^a   Fujii, Akihiro ^a   Sakai, Kaoru ^a   Imada, Teruaki ^a  

^a Benesis Corporation   (Japan)

Author keywords

Intravenous immunoglobulin; LPS; Macrophages; NF B; TNF

Indexed keywords

CYTOKINE; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN FC FRAGMENT; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; INFLAMMATION; MOLECULAR MECHANICS; PERIPHERAL BLOOD MONONUCLEAR CELL; SIGNAL TRANSDUCTION;

ADULT; CELL LINE; CELLS, CULTURED; CYTOKINES; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MAP KINASE SIGNALING SYSTEM; MONOCYTES; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84866739940     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0765-8     Document Type: Article

References (37)

1. Abe Y, Horiuchi A, Miyake M, Kimura S (1994) Anti-cytokine nature of natural human immunoglobulin: one possible mechanism of the clinical effect of intravenous immunoglobulin therapy. Immunol Rev 139:5-19
2. Adib-Conquy M, Cavaillon JM (2009) Compensatory antiinflammatory response syndrome. Thromb Haemost 101:36-47
3. Andersson U, Bjork L, Skansen-Saphir U, Andersson J (1994) Pooled human IgG modulates cytokine production in lymphocytes and monocytes. Immunol Rev 139:21-42
4. Campbell DE, Georgiou GM, Kemp AS (1999) Pooled human immunoglobulin inhibits IL-4 but not IFN-gamma or TNF-alpha secretion following in vitro stimulation of mononuclear cells with staphylococcal superantigen. Cytokine 11:359-365
5. Furukawa S, Matsubara T, Yone K, Hirano Y, Okumura K, Yabuta K (1992) Kawasaki disease fifers from anaphylactoid purpura and measles with regard to tumour necrosis factor-α and interleukin 6 in serum. Eur J Pediatr 151:44-47
6. Furusho K, Nakano H, Shinomiya K, Tamura T, Manabe Y, Kawarano M, Baba K, Kamiya T, Kiyosawa N, Hayashidera T, Hirose O, Yokoyama T, Baba K, Mori C (1984) High-dose intravenous gammaglobulin for Kawasaki disease. Lancet 2:1055-1058
7. Guha M, Mackman N (2001) LPS induction of gene expression in human monocytes. Cell Signal 13:85-94
8. Hagiwara S, Iwasaka H, Hasegawa A, Asai N, Noguchi T (2008) Highdose intravenous immunoglobulin G improves systemic inflammation in a rat model of CLP-induced sepsis. Intensive Care Med 34:1812-1819
9. Ichiyama T, Ueno Y, Hasegawa M, Niimi A, Matsubara T, Furukawa S (2004) Intravenous immunoglobulin inhibits NF-κB activation and affects Fcγ receptor expression in monocytes/macrophages. Naunyn-Schmied Arch Pharmacol 369:428-433
10. Iwata M, Shimozato T, Tokiwa H, Tsubura E (1987) Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits. Infect Immun 55:547-554
11. Kazatchkine MD, Kaveri SV (2001) Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin. N Engl J Med 345:747-755
12. Kreymann KG, de Heer G, Nierhaus A, Kluge S (2007) Use of polyclonal immunoglobulins as adjunctive therapy for sepsis or septic shock. Crit Care Med 35:2677-2685
13. Laupland KB, Kirkpatrick AW, Delaney A (2007) Polyclonal intravenous immunoglobulins for the treatment of severe sepsis and septic shock in critically ill adults: a systematic review and meta-analysis. Crit Care Med 35:2686-2692
14. Li S, Zhang J (2009) Lipopolysaccharide induces autotoxin expression in human monocytic THP-1 cells. Biochem Biophys Res Commun 378:264-268
15. Lin CY, Lin CC, Hwang B, Chiang B (1992) Serial changes of serum interleukin-6, interleukin-8, and tumor necrosis factor α among patients with Kawasaki disease. J Pediatr 121:924-926
16. Maury CPJ, Salo E, Pelkonen P (1988) Circulating interleukin-1β in patients with Kawasaki disease. N Engl J Med 319:1670-1671
17. Negi VS, Elluru S, Siberil S, Graff-Dubois S, Mouthon L, Kazatchkine MD, Lacroix-Desmazes S, Bayry J, Kaveri SV (2007) Intravenous immunoglobulin: an update on the clinical use and mechanisms of action. J Clin Immunol 27:233-245
18. Newburger JW, Takahashi M, Burns JC, Beiser AS, Chung KJ, Duffy CE, Glode MP, Mason WH, Reddy V, Sanders SP, Shulman ST, Wiggins JW, Hicks RV, Fulton DR, Lewis AB, Leung DYM, Colton T, Rosen FS, Melish ME (1986) The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med 315:341-347
19. Oberholzer A, Oberholzer C, Moldawer LL (2001) Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16:83-96
20. Park EK, Jung HS, Yang HI, Yoo MC, Kim KS (2007) Optimized THP-1 differentiation is required for the detection of responses to weak stimuli. Inflamm Res 56:45-50
21. Parr D, Connell G, Kells D, Hofmann T (1976) Fb'2, a new peptic fragment of human immunoglobulin G. Biochem J 155:31-36
22. Pollack M (1983) Antibody activity against Pseudomonas aeruginosa in immune globulins prepared for intravenous use in human. J Infect Dis 147:1090-1098
23. Rhoades CJ, Williams MA, Kelsey SM, Newland AC (2000) Monocyte-macrophage system as targets for immunomodulation by intravenous immunoglobulin. Blood Rev 14:14-30
24. Saito T, Kimura S, Tateda K, Mori N, Hosono N, Hayakawa K, Akasaka Y, Ishii T, Sumiyama Y, Kusachi S, Nagao J, Yamaguchi K (2011) Evidence of intravenous immunoglobulin as a critical supportive therapy against Clostridium difficile toxin-mediated lethality in mice. J Antimicrob Chemother 66:1096-1099
25. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3:1101-1108
26. Sharif O, Bolshakov VN, Raines S, Newham P, Perkins ND (2007) Transcriptional profiling of the LPS induced NF-κB response in macrophages. BMC Immunol 8:1-17
27. Shimozato T, Iwata M, Kawada TN (1991) Human immunoglobulin preparation for intravenous use induces elevation of cellular cyclic adenosine 3':5'-monophosphate levels, resulting in suppression of tumour necrosis factor alpha and interleukin-1 production. Immunology 72:497-501
28. Snigurowicz J, Powiertowska-Rezmer M (1980) Papain hydrolysis products in four M-IgG subclass. Arch Immunol Ther Exp 28:265-273
29. Sunden-Cullberg J, Norrby-Teglund A, Treutiger CJ (2006) The role of high mobility group box-1 protein in severe sepsis. Curr Opin Infect Dis 19:231-236
30. Takata Y, Seki S, Dobashi H, Takeshita S, Nakatani K, Kamezawa Y, Hiraide H, Sekine I, Yoshioka S (1998) Inhibition of IL-12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD). Clin Exp Immunol 114:311-319
31. Toungouz M, Denys CH, Groote DD, Dupont E (1995) In vitro inhibition of tumour necrosis factor-α and interleukin-6 production by intravenous immunoglobulins. Br J Haematol 89:698-703
32. Ulloa L, Tracey KJ (2005) The 'cytokine profile': a code for sepsis. Trends Mol Med 11:56-63
33. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251
34. Wu KH, Wu WM, Lu MY, Chiang BL (2006) Inhibitory effect of pooled human immunoglobulin on cytokine production in peripheral blood mononuclear cells. Pediatr Allergy Immunol 17:60-68
35. Wu W, Alexis NE, Chen X, Bromberg PA, Peden DB (2008) Involvement of mitogen-activated protein kinases and NF-κB in LPSinduced CD40 expression on human monocytic cells. Toxicol Appl Pharmacol 228:135-143
36. Yanagisawa C, Hanaki H, Natae T, Sunakawa K (2007) Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulin. J Infect Chemother 13:368-372
37. Yang H, Tracey KJ (2010) Targeting HMGB1 in inflammation. Biochim Biophys Acta 1799:149-156